Tysabri

FDA Approves Sandoz Biosimilar to Biogen’s MS Therapy Tysabri
BioSpace
Fri, 08/25/23 - 09:53 am
Biogen
Sandoz
FDA
biosimilars
MS
multiple sclerosis
Tysabri
Roche sues Biogen over royalties related to multiple sclerosis drug Tysabri
Fierce Pharma
Wed, 03/1/23 - 07:08 pm
Roche
Genentech
patents
MS
multiple sclerosis
legal
Tysabri
Unsealed documents detail Biogen's fight against Sandoz Tysabri biosimilar
Endpoints
Tue, 09/20/22 - 08:36 pm
Biogen
Novartis
Sandoz
biosimilars
Tysabri
MS
multiple sclerosis
Biogen, watch out: Novartis' Tysabri biosim application could portend multiple sclerosis showdown in Europe and US
Fierce Pharma
Wed, 07/27/22 - 10:58 am
Novartis
Biogen
multiple sclerosis
MS
Tysabri
biosimilars
Novartis asks FDA to approve biosimilar for Biogen’s top-selling MS drug
BioPharma Dive
Mon, 07/25/22 - 09:54 pm
Novartis
FDA
Biogen
biosimilars
Tysabri
MS
multiple sclerosis
New MS Trial Will be First to Compare Stem Cell Therapy with Best Available Biologics
Xtalks
Mon, 01/13/20 - 11:35 pm
stem cells
MS
multiple sclerosis
NIH
AHSCT
Biogen
Tysabri
Sanofi
Lemtrada
Roche
Ocrevus
Rituxan
Novartis strikes marketing deal for Polpharma’s potential Tysabri biosimilar
Pharmaforum
Tue, 09/3/19 - 10:30 am
Novartis
Sandoz
generics
biosimilars
Tysabri
Polpharma
Biogen scuttles a Tysabri program after the drug fails stroke test, thinning the pipeline
Endpoints
Wed, 02/7/18 - 10:03 am
Biogen
Tysabri
ischemic stroke
How Biogen Inc. Makes Most of Its Money
Motley Fool
Thu, 07/13/17 - 05:43 pm
Biogen
Tecfidera
Tysabri
MS
multiple sclerosis
Why Roche's New Drug Is Bad News For Biogen
Barron's
Sun, 04/9/17 - 12:20 pm
Roche
Biogen
Ocrevus
multiple sclerosis
MS
Tysabri
Tecfidera
Biogen Inc MS Drugs: Deadly Cash Cows?
Bidness, ETC
Fri, 08/5/16 - 11:28 am
Biogen
MS
multiple sclerosis
Tecfidera
Avonex
Tysabri
Plegridy
Perrigo Can Reach $200 If It Keeps Tysabri Royalties, Lot More If It Sells Them
Seeking Alpha
Wed, 06/11/14 - 10:29 am
Perrigo
Tysabri
Biogen shares could rise 20% on robust drug pipeline, Barron's contends
The Fly on the Wall
Fri, 05/23/14 - 06:58 am
Biogen Idec
Tysabri
Avonex
Tecfidera
Eloctate
Alprolix
Catalyst For Perrigo: Sale Of Tysabri Royalties
Seeking Alpha
Thu, 05/22/14 - 11:55 am
Perrigo
Tysabri
Biogen Idec
Elan sees sales of prized Tysabri drug rise sharply
Reuters
Wed, 04/24/13 - 08:46 am
Elan
Royalty Pharma
M&A
Tysabri
Elan completes sale of Tysabri stake to Biogen
Reuters
Wed, 04/3/13 - 10:51 am
Tysabri
Elan
Biogen Idec
MS
multiple sclerosis
Elan offers Tysabri dividend, dismisses Royalty offer
Reuters
Mon, 03/4/13 - 10:38 am
Elan
dividends
Tysabri
Royalty Pharma
Elan to return $1 billion to shareholders from multiple sclerosis drug sale
Reuters
Fri, 02/22/13 - 10:44 am
Elan
Tysabri
share repurchase
A Strong Growth Opportunity In Multiple Sclerosis
Motley Fool
Wed, 02/20/13 - 11:46 am
multiple sclerosis
MS
Elan
Biogen Idec
Tysabri
Teva
XenoPort
Sanofi
BG-12
Elan seeks acquisitions after $3.25 bn Biogen Idec deal, rival Bayer eyed on MS treatments
Financial Express
Thu, 02/7/13 - 11:03 am
Elan
Bayer
M&A
Biogen Idec
Tysabri

Pages